Isracann Biosciences Inc. announced a a non-brokered private placement of 500,000 units at an issue price of CAD 0.05 for the gross proceeds of CAD 25,000 on February 16, 2023. Each Unit consists of one common share and one common share purchase warrant. Each Warrant entitles the holder to acquire one additional Share at a price of CAD 0.055 per Warrant Share for 48 months from the date of issuance.

All securities issued in connection with the transaction will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities laws ending on June 17, 2023.